Remdesivir COVID-19 Treatment: Dosage, Effectiveness & Guidelines

Summary of Key Points

Remdesivir is an antiviral medication used to treat certain viral infections, including COVID-19. It works by inhibiting the virus’s ability to replicate, which helps reduce the severity of the illness. Remdesivir is typically administered in a hospital or healthcare setting. Always consult your healthcare provider before starting or adjusting your dose. You can also schedule a telemedicine appointment with one of our providers for more information.

Names of Medication

US Brand Name: Veklury

Generic Name: Remdesivir

The generic name refers to the active ingredient in the medication, while the brand name is assigned by the manufacturer. In this article, the generic name will be listed in parentheses.

Pharmacologic Category

Antiviral Agent, RNA Polymerase Inhibitor

Remdesivir Dosing Guidelines

Remdesivir is used to treat various viral infections. The dosing regimen depends on the specific condition being treated. Always follow your healthcare provider’s instructions and consult them before making any changes to your dose. You can also speak with one of our telemedicine providers for personalized guidance.

Remdesivir for COVID-19 (Coronavirus Disease 2019)

Initial Dose: 200 mg IV (intravenous) on Day 1

Maintenance Dose: 100 mg IV once daily for 4 days (or up to 9 days if needed)

Duration: Typically 5 days, but may be extended to 10 days depending on the severity of the illness

Remdesivir for Ebola Virus Disease

Initial Dose: 200 mg IV on Day 1

Maintenance Dose: 100 mg IV once daily for 9 days

Duration: 10 days

Remdesivir for Marburg Virus Disease

Initial Dose: 200 mg IV on Day 1

Maintenance Dose: 100 mg IV once daily for 9 days

Duration: 10 days

Remdesivir for SARS (Severe Acute Respiratory Syndrome)

Initial Dose: 200 mg IV on Day 1

Maintenance Dose: 100 mg IV once daily for 4 days

Duration: 5 days

Remdesivir for MERS (Middle East Respiratory Syndrome)

Initial Dose: 200 mg IV on Day 1

Maintenance Dose: 100 mg IV once daily for 4 days

Duration: 5 days

Remdesivir for Hantavirus Infection

Initial Dose: 200 mg IV on Day 1

Maintenance Dose: 100 mg IV once daily for 9 days

Duration: 10 days

Remdesivir for Crimean-Congo Hemorrhagic Fever

Initial Dose: 200 mg IV on Day 1

Maintenance Dose: 100 mg IV once daily for 9 days

Duration: 10 days

Remdesivir for Lassa Fever

Initial Dose: 200 mg IV on Day 1

Maintenance Dose: 100 mg IV once daily for 9 days

Duration: 10 days

Remdesivir for Nipah Virus Infection

Initial Dose: 200 mg IV on Day 1

Maintenance Dose: 100 mg IV once daily for 9 days

Duration: 10 days

Remdesivir for Zika Virus Infection

Initial Dose: 200 mg IV on Day 1

Maintenance Dose: 100 mg IV once daily for 9 days

Duration: 10 days

Dosage Forms and Strengths of Remdesivir

Injection: 100 mg/20 mL (5 mg/mL) solution in a single-dose vial

Injection: 100 mg lyophilized powder in a single-dose vial for reconstitution

Administration Instructions for Remdesivir

Remdesivir is administered as an intravenous (IV) infusion, meaning it is delivered directly into a vein. The infusion typically takes between 30 and 120 minutes. It is usually given in a hospital or healthcare setting under the supervision of a healthcare professional. If you have any questions about how Remdesivir is administered, consult your healthcare provider or schedule a telemedicine appointment with one of our providers.

Contraindications for Remdesivir

A contraindication is a specific situation where a medication should not be used because it may be harmful. For Remdesivir, certain conditions make it unsafe or inappropriate. If you have any of the following conditions, discuss them with your healthcare provider before starting Remdesivir.

1. Severe renal impairment (eGFR < 30 mL/min): Remdesivir is primarily excreted by the kidneys. In patients with severe kidney issues, the drug may accumulate, leading to potential toxicity.
2. Hypersensitivity to Remdesivir or any of its components: If you have had an allergic reaction to Remdesivir or its ingredients, taking it again could cause a serious allergic reaction, including anaphylaxis.
3. Pre-existing liver disease: Remdesivir can elevate liver enzymes, potentially worsening liver function in patients with existing liver disease. Monitoring liver function during treatment is crucial.

Drug-to-Drug Interactions with Remdesivir

Remdesivir can interact with other medications, affecting how it works or increasing the risk of side effects. Inform your healthcare provider about all the medications you are taking, including prescription drugs, over-the-counter medications, and supplements.

1. Chloroquine or Hydroxychloroquine (Plaquenil): These medications may reduce the antiviral activity of Remdesivir, making it less effective in treating viral infections like COVID-19.
2. Rifampin (Rifadin): Rifampin is a strong inducer of liver enzymes that can decrease the effectiveness of Remdesivir by speeding up its breakdown in the body.
3. Phenytoin (Dilantin): Like Rifampin, Phenytoin can increase the metabolism of Remdesivir, potentially reducing its antiviral effects.

Remdesivir in Pregnancy

Is it safe to take Remdesivir when pregnant?

There is limited information on the use of Remdesivir in pregnant women. While animal studies have not shown harm to the fetus, data from human studies is still insufficient. The decision to use Remdesivir during pregnancy should be made in close consultation with your healthcare provider, carefully considering the potential benefits and any possible risks. If you are pregnant and considering Remdesivir treatment, it is essential to discuss your options with a healthcare professional. You can schedule a telemedicine visit with one of our providers to receive personalized advice.

Remdesivir while Breastfeeding

Is it safe to take Remdesivir while breastfeeding?

Currently, there is no available data on whether Remdesivir passes into human breast milk, its effects on a breastfed infant, or its impact on milk production. Given this lack of information, it is important to consult your healthcare provider to weigh the potential benefits and risks of using Remdesivir while breastfeeding. If you are breastfeeding and need guidance, you can speak with one of our providers through a telemedicine appointment.

Estimated Cost of Remdesivir

The estimated cost of a 30-day supply of Remdesivir without insurance, using a GoodRX coupon, ranges from approximately $2,340 to $3,120. Prices may vary depending on the pharmacy and location. It is advisable to check with your pharmacy for the most accurate pricing.

Possible Alternatives to Remdesivir

If Remdesivir is not suitable for you, or if you are exploring additional treatment options, there are alternatives that may help. Be sure to discuss these options with your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine visit with one of our providers to explore these alternatives further.

COVID-19 Treatment Alternatives

For COVID-19, alternatives include monoclonal antibodies (e.g., Regeneron), antiviral medications like Paxlovid, and supportive care such as oxygen therapy. Preventive measures, including vaccination, wearing masks, and social distancing, are also crucial.

Ebola Virus Disease Treatment

Treatments for Ebola virus disease include monoclonal antibodies (such as Inmazeb) and supportive care, including fluid replacement and blood pressure management.

Marburg Virus Disease Treatment

For Marburg virus disease, supportive care is the primary treatment, focusing on fluid replacement and managing complications. Experimental treatments are currently under investigation.

SARS Treatment

For SARS, supportive care, including oxygen therapy and mechanical ventilation, is the main treatment. Antiviral medications and corticosteroids may also be used in some cases.

MERS Treatment

For MERS, supportive care, including oxygen therapy and mechanical ventilation, is the primary treatment. Experimental antiviral therapies are being studied.

Hantavirus Infection Treatment

For Hantavirus infection, supportive care, including oxygen therapy and mechanical ventilation, is the main treatment. Early recognition and intervention are critical for improving outcomes.

Crimean-Congo Hemorrhagic Fever Treatment

For Crimean-Congo hemorrhagic fever, Ribavirin, an antiviral medication, may be used in some cases. Supportive care is also essential for managing symptoms.

Lassa Fever Treatment

For Lassa fever, Ribavirin is the primary antiviral treatment, and supportive care plays a key role in managing the disease.

Nipah Virus Infection Treatment

For Nipah virus infection, there is no specific treatment available. Supportive care, including respiratory support, is critical. Experimental treatments are being explored.

Zika Virus Infection Treatment

For Zika virus infection, there is no specific antiviral treatment. Supportive care, including rest, hydration, and pain relief, is recommended to manage symptoms.

Recent Updates on Remdesivir Research

Recent studies continue to evaluate the effectiveness of Remdesivir in treating COVID-19 and other viral infections. A study published in 2022 found that early administration of Remdesivir in non-hospitalized patients with mild to moderate COVID-19 reduced the risk of hospitalization and death. Ongoing research is also exploring the use of Remdesivir in combination with other antiviral therapies to enhance its effectiveness against a broader range of viruses, including emerging variants of SARS-CoV-2.

Additionally, clinical trials are investigating the use of Remdesivir for other viral infections, such as Ebola and Marburg virus. These studies aim to determine whether Remdesivir can be a viable treatment option for these diseases. If you are interested in learning more about the latest research or participating in a clinical trial, you can consult with one of our providers through a telemedicine appointment.

James Kingsley

Learn More